Elevance Health, Inc. - Common Stock (ELV)

CUSIP: 036752103

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
225,970,109
Total 13F shares
216,717,748
Share change
-4,017,549
Total reported value
$69,548,509,680
Put/Call ratio
126%
Price per share
$321.09
Number of holders
1,152
Value change
-$1,210,346,982
Number of buys
476
Number of sells
490

Quarterly Holders Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2020

As of 31 Dec 2020, Elevance Health, Inc. - Common Stock (ELV) was held by 1,152 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 216,717,748 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Capital International Investors, BAILLIE GIFFORD & CO, GEODE CAPITAL MANAGEMENT, LLC, and BANK OF AMERICA CORP /DE/. This page lists 1,153 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.